Reduced-dose apixaban proves effective in preventing blood clot recurrence in cancer

[News]

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 months of low-dose apixaban, experienced similar VTE recurrences and less bleeding as similar patients who received a full dose of the oral blood-thinning medication over the same extended period.

More... (https://www.news-medical.net/news/20250329/Reduced-dose-apixaban-proves-effective-in-preventing-blood-clot-recurrence-in-cancer-patients.aspx)